BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 599799)

  • 1. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
    Savenkov PM; Doshitsin VL; Grudtsyn GV
    Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of Visken-15 for treating hypertension].
    Erina EV; Megrelishvili RI; Pushkar' IuT; Beliakova EV; Lediashova GA
    Kardiologiia; 1979 Mar; 19(3):46-52. PubMed ID: 372668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP; Korner PI; Tiller DJ; Bune AJ; Steiner JD; West MJ; Wing LM; Uther JF
    Med J Aust; 1976 May; 1(18):650-3. PubMed ID: 781495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The characteristics of using visken in middle-aged and elderly patients with arterial hypertension].
    Tokar AV; Iena LM; Kozymenko TM; Shyshkina OS
    Lik Sprava; 1993; (10-12):34-8. PubMed ID: 8030304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
    Torres Zamora M
    Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of beta-adrenergic blockaders in the treatment of arterial hypertension].
    Erina EV; Basishvili NZ
    Kardiologiia; 1978 Mar; 18(3):28-35. PubMed ID: 25351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of visken and hyperstat in hypertensive crisis].
    Gorbacgenkov AA; Savenkov PM; Klevtsova MN; Ozherel'eva NI; Albegov AS
    Kardiologiia; 1979 Aug; 19(8):95-9. PubMed ID: 491366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A controlled clinical therapeutic trial of prindolol in patients with arterial hypertension (author's transl)].
    Marinković M; Winter-Fudurić ; Kuzmanić D
    Lijec Vjesn; 1976 Apr; 98(4):172-6. PubMed ID: 787710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Change in the central and regional (brain) hemodynamics in the treatment of hypertension using beta-adrenergic blockaders].
    Erina EV; Basishvili NZ; Elizarova NA; Kheĭmets GI
    Kardiologiia; 1976 Jul; 16(7):82-7. PubMed ID: 10464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension].
    Klein WW; Brandt D; Fluch N; Goebel R; Holzer H; Pöch G
    Adv Clin Pharmacol; 1976; 11():79-85. PubMed ID: 1032573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of prindolol on the blood-pressure profile of hypertensives (with special consideration of response to exercise and plasma-renin activity) (author's transl)].
    Dufey K; Krönig B; Fries G; Gunkel R; Walter U; Wolff HP
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1726-30. PubMed ID: 1157670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled study of prindolol (Visken) in hypertension.
    Thorpe P
    Med J Aust; 1972 Aug; 2(6):306-9. PubMed ID: 4563156
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of visken and hypothiazide on the indices of the central and renal hemodynamics in patients with atherosclerotic hypertension].
    Shishkina OS
    Vrach Delo; 1990 Apr; (4):41-3. PubMed ID: 2275163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of beta-blockader visken in children with primary arterial hypertension].
    Nadezhdina EA; Vul'fson IN; Ivanitskaia IN; Kurbatov VS; Kupriianova OO
    Kardiologiia; 1976 May; 16(5):71-5. PubMed ID: 7701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamics after prindolol and digitalis in acute myocardial infarction (author's transl)].
    Bachour G; Bender F; Hochrein H
    Med Klin; 1976 Mar; 71(10):414-20. PubMed ID: 57564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
    Barnett AJ; Kalowski S; Guest C
    Med J Aust; 1978 Jan; 1(2):105-9. PubMed ID: 349319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Haemodynamic effect of short-term adrenergic block with prindolol at rest and during strain in hypertonic subjects (stage II)].
    Ressl J; Chrástek J; Jandová R; Nhon TQ
    Cas Lek Cesk; 1974 Oct; 113(43):1317-21. PubMed ID: 4429976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.